Sidley is representing CA Healthcare Acquisition Corp., a special purpose acquisition company focused on investing in a growth-oriented healthcare company, in its pending business combination with LumiraDx Limited, a next-generation point of care diagnostics testing company. The transaction has an implied pro forma equity value of US$5.1 billion.  See full article here.

See all Member News